新型冠状病毒

CDC panel backs BioNTech/Pfizer booster for elderly and at-risk groups

Experts narrow qualifications for third jab in latest setback to Biden’s booster programme

The Biden administration’s plan for a widespread booster programme was dealt another blow as a panel of advisers to the top public health agency recommended that a third dose be offered only to the elderly and people with underlying health conditions but not those working in jobs with high risk of Covid-19 exposure.

The vaccine committee advising the US Centers for Disease Control and Prevention voted unanimously to recommend booster doses of the BioNTech/Pfizer vaccine to people aged over 65 years and care home residents, and 13-2 to approve boosters for people aged 50-64 with underlying medical conditions.

The committee voted 9-6 to offer boosters to people aged over 18 with underlying health conditions, a group comprising at least 50m people according to CDC data. However, the panel rejected endorsing a third jab for those working in jobs with high risk of exposure to Covid, in a 9-6 vote.

您已阅读24%(903字),剩余76%(2839字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×